Drug Shortage Report for HP-PAC
| Report ID | 32477 |
| Drug Identification Number | 02238525 |
| Brand name | HP-PAC |
| Common or Proper name | LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN |
| Company Name | TAKEDA PHARMACEUTICALS AMERICA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN |
| Strength(s) | 500MG 30MG 500MG |
| Dosage form(s) | KIT CAPSULE CAPSULE (SUSTAINED-RELEASE) TABLET |
| Route of administration | ORAL |
| Packaging size | Blister pack |
| ATC code | A02BD |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2018-05-07 |
| Estimated end date | |
| Actual end date | 2018-06-25 |
| Shortage status | Resolved |
| Updated date | 2018-06-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 95 HAYDEN AVENUE LEXINGTON, MASSACHUSETTS UNITED STATES 02421 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.